Cydonii V. Fairfax
CIK: 0002031393
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VSEE HEALTH, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 4, 2026VSEE
VSEE HEALTH, INC.
Award(A)Direct40.1K shares at avg. $0.37$15K - Sep 19, 2025VSEE
VSEE HEALTH, INC.
Award(A)Direct21.9K shares at avg. $0.69$15K - Sep 19, 2025VSEE
VSEE HEALTH, INC.
Award(A)Direct12.9K shares at avg. $1.16$15K - Sep 19, 2025VSEE
VSEE HEALTH, INC.
Award(A)Direct12.5K shares at avg. $1.20$15K - Sep 19, 2025VSEE
VSEE HEALTH, INC.
Award(A)Direct11K shares at avg. $1.36$15K - Sep 19, 2025VSEE
VSEE HEALTH, INC.
Award(A)Direct10.1K shares at avg. $1.49$15K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 4, 2026 | VSEE VSEE HEALTH, INC. | Award(A) | 40,107 | $0.37 | $15,000 | Direct |
| Sep 19, 2025 | VSEE VSEE HEALTH, INC. | Award(A) | 21,870 | $0.69 | $15,090 | Direct |
| Sep 19, 2025 | VSEE VSEE HEALTH, INC. | Award(A) | 12,931 | $1.16 | $15,000 | Direct |
| Sep 19, 2025 | VSEE VSEE HEALTH, INC. | Award(A) | 12,500 | $1.20 | $15,000 | Direct |
| Sep 19, 2025 | VSEE VSEE HEALTH, INC. | Award(A) | 11,029 | $1.36 | $14,999 | Direct |
| Sep 19, 2025 | VSEE VSEE HEALTH, INC. | Award(A) | 10,067 | $1.49 | $15,000 | Direct |
1-6 of 6 transactions
About FAIRFAX CYDONII V.
FAIRFAX CYDONII V. (SEC CIK 0002031393) files insider reports with the SEC as Director of VSEE HEALTH, INC. (VSEE).
Signal8 holds 2 ownership filings by FAIRFAX CYDONII V., all Form 4s, filed between Jan 16, 2026 and Mar 5, 2026. Those filings report 6 transactions, from Sep 19, 2025 to Mar 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FAIRFAX CYDONII V.'s filings is in BOCA RATON, FL.
Recent filings by FAIRFAX CYDONII V.
Other insiders filing for VSEE HEALTH, INC. (VSEE)
- CHEN MILTON, Co-Chief Executive Officer
- Leonard Jerry, Chief Financial Officer
- Aisiku Imoigele, Co-Chief Executive Officer
- O'SULLIVAN COLIN P., Director
- METZGER SCOTT, Director
- LOWDERMILK KEVIN, Director